Skip to main content
. 2021 Jan 28;11:609490. doi: 10.3389/fimmu.2020.609490

Figure 3.

Figure 3

Development of a syngeneic mouse model using a B16F10 melanoma cell line stably overexpressing mIDO1. (A) Analysis of mIDO1 mRNA levels by qPCR in the parental B16F10 cell line and two mIDO1-transfected stable sublines (i6 and j19). mRNA levels were normalized for the expression of three housekeeping genes (ACTB, GAPDH, and RPL37), and scaled based on the hepatoma Hepa 1-6 cell line stimulated with IFNγ (included as a positive control). (B) Immunoblot analysis of the parental B16F10 cell line and mIDO1-overexpressing sublines. (C) Mean tumor volume after implantation of the B16F10-mIDO1 i6 and j19 sublines in B6D2F1 mice. Results are expressed as mean ± SEM. (D) Analysis of mIDO1 mRNA levels in the tumor tissues by qPCR. mRNA levels are scaled based on the mRNA level of the B16F10-mIDO1 subline j19 in cell culture. (E) Intratumoral Trp and (F) Kyn levels as determined by LC-MS/MS. LLOQ in (E, F) indicates the lower limit of quantification of the experiment. Results of (D–F) are expressed as mean ± SD.